semaglutide and bone loss A study presented at the #AAOS2026 Annual Meeting revealed GLP-1 receptor agonist use was associated with a 29% higher risk of osteoporosis after five years. As these medications become more widely used Frontiers | Bone mineral density

More on that later

2 Left untreated, MASH can progress to serious and even fatal outcomes, such as cirrhosis, liver cancer, and the need for liver transplant 3 Additionally, Novo Nordisk's application for Wegovy (semaglutide) injection 2.4 mg for the treatment of metabolic dysfunction-associated steatohepatitis (MASH) was recently accepted by FDA and granted Priority Review PLAINSBORO, N.J., April 30, 2025 /PRNewswire/ -- Today, The New England Journal of Medicine (NEJM) published results from part 1 of the ongoing phase 3 ESSENCE trial which investigated the effects of once-weekly subcutaneous semaglutide 2.4 mg on liver histology compared to placebo at 72 weeks in adults with MASH and moderate to advanced liver fibrosis (stage 2 or 3)

Key Differences Between Semaglutide And Mounjaro While both medications help regulate blood sugar and support weight loss, they work in slightly different ways and may have different results

Benefits of Vitamin B12 Injections 1